Venous thromboembolism in women on estrogen therapy: presentation, management, and outcomes in the RIETE registry

Blood Advances 2026 Open access

Read full text
Authors: Andreas Verstraete, Thomas Vanassche, Angeles Blanco-Molina, Juan Criado-García, Quentin Van Thillo, Montserrat Pérez‐Pinar, Judith Catella, Saskia Middeldorp, Peter Verhamme, Manuel Monréal
DOI: 10.1182/bloodadvances.2026020383
Cited by: 1
References: 31

Abstract

ABSTRACT: Combined oral contraceptives increase the venous thromboembolism (VTE) risk nearly fivefold. Their widespread use translates into a substantial number of VTE events in otherwise healthy young women. However, data on estrogen-associated VTE remain limited. We used data from the RIETE registry (2011-2024), including patients without cancer

Fields of Study & Subjects

Venous Thromboembolism Diagnosis and Management Blood Coagulation and Thrombosis Mechanisms Reproductive Health and Contraception

Publication details

Journal / source
Blood Advances
Publisher
American Society of Hematology
Volume
10
Issue
18
Pages
6153–6163
Publication date
30 June 2026
Language
EN